Pages that link to "Q40714158"

The following pages link to A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease (Q40714158):

Displaying 30 items.

• Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age (Q24245934) (← links)
• Sickle cell disease in childhood: from newborn screening through transition to adult medical care (Q27693325) (← links)
• Preventing morbidity and mortality from sickle cell disease. A public health perspective (Q33644866) (← links)
• How I treat acute chest syndrome in children with sickle cell disease (Q34170948) (← links)
• Aetiology and management of children with acute fever of unknown origin (Q34224058) (← links)
• Prevention and management of infection in children with sickle cell anaemia (Q34458615) (← links)
• Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections (Q34621459) (← links)
• Salmonella epidural abscess in sickle cell disease: failure of the nonsurgical treatment. (Q35598628) (← links)
• A validated measure of adherence to antibiotic prophylaxis in children with sickle cell disease (Q37007278) (← links)
• Chart Card: Feasibility of a Tool for Improving Emergency Department Care in Sickle Cell Disease (Q37108110) (← links)
• Incidence of serious bacterial infections in febrile children with sickle cell disease (Q38105537) (← links)
• Improving outcomes in children with sickle cell disease: treatment considerations and strategies (Q38209472) (← links)
• How we prevent and manage infection in sickle cell disease (Q38505129) (← links)
• Outpatient Management of Febrile Children With Sickle Cell Disease (Q40148446) (← links)
• Initial approach to the child who presents with sickle-cell disease and fever. (Q40478133) (← links)
• Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia (Q42279188) (← links)
• The ASPHO 2015 Distinguished Career Award Goes to Dr. Winfred C. Wang, MD. (Q43549284) (← links)
• Ceftriaxone. A pharmacoeconomic evaluation of its use in the treatment of serious infections (Q43787795) (← links)
• Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease (Q44030924) (← links)
• Fatal pneumococcal septicemia in hemoglobin SC disease (Q44851767) (← links)
• Sickle cell disease: New opportunities and challenges in Africa (Q53127392) (← links)
• Telephone contact of patients visiting a large, municipal Emergency Department: Can we rely on numbers given during routine registration? (Q63819665) (← links)
• Sickle cell disease (Q71124257) (← links)
• Home intravenous anti-infective therapy (HIVAT): do the benefits outweigh the risks? (Q71273778) (← links)
• The febrile child with sickle cell disease: a pediatrician's quandary (Q73341618) (← links)
• Recurrent Streptococcus pneumoniae sepsis in children with sickle cell disease (Q73341656) (← links)
• Sickle cell anemia—how sick (Q73916126) (← links)
• Sickle cell disease (Q78965468) (← links)
• Outcomes of febrile events in pediatric patients with sickle cell anemia (Q90706125) (← links)
• Telephone follow-up after the emergency department visit: experience with acute asthma (Q95780977) (← links)